Prospective Analysis of Malignant Biliary Stricture Diagnosis: Experience from a Tertiary-Care Hospital

Authors

DOI:

https://doi.org/10.22516/25007440.1455

Keywords:

Bile ducts, stricture, cholangiocarcinoma, endoscopic retrograde cholangiopancreatography

Abstract

Introduction: Malignant biliary strictures represent a persistent diagnostic challenge that requires a coordinated multidisciplinary approach to achieve histopathological confirmation. The limited sensitivity of commonly used diagnostic modalities may delay definitive diagnosis and increase healthcare expenditures.

Methods: A prospective study was conducted at a tertiary-care hospital in Panama involving patients with malignant biliary strictures (MBS) who underwent drainage via endoscopic retrograde cholangiopancreatography (ERCP). Patients were followed for 12 months, during which all therapeutic and diagnostic procedures, time to histological confirmation, and associated costs were documented. A ROC-curve analysis was performed to determine optimal cutoff values for predictive variables associated with MBS.

Results: A total of 147 patients with MBS were included, with distal strictures being the most frequent presentation (74%). Pancreatic cancer was the leading underlying malignancy (46.2%), followed by cholangiocarcinoma (36.7%). Cholangiocarcinoma exhibited a notably high proportion of unconfirmed histopathological diagnoses (39%) and incurred the greatest diagnostic costs, with an estimated mean expenditure of USD 12,000. In ROC analyses, the cutoffs associated with malignancy were total bilirubin >8.9 mg/dL, stricture length >1.5 cm, and CA 19-9 >35 U/mL.

Conclusion: Elevated total bilirubin levels, longer stricture length, and higher CA 19-9 concentrations emerged as predictive factors for MBS. Conventional ERCP-based diagnostic techniques, including brush cytology and biopsy, demonstrated limited diagnostic accuracy, necessitating the use of alternative methods, repeated procedures, and consequently higher costs. Standardizing diagnostic protocols that prioritize more sensitive and specific modalities is essential to enhance diagnostic efficiency and improve care for patients with suspected MBS.

Downloads

Download data is not yet available.

Author Biographies

Julio Zuñiga Cisneros, Universidad de Panamá

Gastroenterologist, Medical School, Universidad de Panamá. Department of Gastroenterology, Panama Oncology Institute. Panama City, Panama.

Calixto Duarte-Chang, Ministerio de Salud de Panamá

Gastroenterologist, Ministry of Health of Panama. Head, Department of Gastroenterology, Hospital San Miguel Arcángel. Panama City, Panama.

Alexis McKenzie, Caja de Seguro Social de Panamá

Gastroenterologist, Panama Social Security Fund. Department of Gastroenterology, Complejo Hospitalario Metropolitano de Panamá. Panama City, Panama.

Orlando Quirós, Caja de Seguro Social de Panamá

Gastroenterologist, Panama Social Security Fund. Department of Gastroenterology, Complejo Hospitalario Metropolitano de Panamá. Panama City, Panama.

Carlos Tuñon, Instituto Oncológico Nacional de Panamá

Gastroenterologist, Head of the Endoscopy Unit, National Oncology Institute of Panama. Medical School, Universidad de Panamá. Panama City, Panama.

References

Elmunzer BJ, Maranki JL, Gómez V, Tavakkoli A, Sauer BG, Limketkai BN, et al. ACG Clinical Guideline: Diagnosis and Management of Biliary Strictures. Am J Gastroenterol. 2023;118(3):405-26. https://doi.org/10.14309/ajg.0000000000002190

Lee HJ, Cho KB. Diagnosis of Malignant Biliary Stricture: More is Better. Clin Endosc. 2018;51(2):115. https://doi.org/10.5946/ce.2018.035

Rushbrook SM, Kendall TJ, Zen Y, Albazaz R, Manoharan P, Pereira SP, et al. British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. Gut. 2023;73(1):16-46. https://doi.org/10.1136/gutjnl-2023-330029

Saluja SS, Sharma R, Pal S, Sahni P, Chattopadhyay TK. Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: A prospective study. HPB. 2007;9 (5):373-82. https://doi.org/10.1080/13651820701504207

Liao W, Wang Q, Jiang Q, Wu X, Yang Y, Yang A. Enhancing diagnostic strategies for biliary strictures: an evolving landscape. Hepatobiliary Surg Nutr. 2024;13(5):885. https://doi.org/10.21037/hbsn-24-447

Dorrell R, Pawa S, Zhou Y, Lalwani N, Pawa R. The diagnostic dilemma of malignant biliary strictures. Diagnostics (Basel). 2020;10(5):337. https://doi.org/10.3390/diagnostics10050337

Al-Mofleh IA, Aljebreen AM, Al-Amri SM, Al-Rashed RS, Al-Faleh FZ, Al-Freihi HM, et al. Biochemical and radiological predictors of malignant biliary strictures. World J Gastroenterol. 2004;10(10):1504. https://doi.org/10.3748/wjg.v10.i10.1504

Mohamadnejad M, Dewitt JM, Sherman S, Leblanc JK, Pitt HA, House MG, et al. Role of EUS for preoperative evaluation of cholangiocarcinoma: A large single-center experience. Gastrointest Endosc. 2011;73(1):71-8. https://doi.org/10.1016/j.gie.2010.08.050

Gonzalo-Marin J, Vila JJ, Perez-Miranda M. Role of endoscopic ultrasound in the diagnosis of pancreatic cancer. World J Gastrointest Oncol. 2014;6(9):360. https://doi.org/10.4251/wjgo.v6.i9.360

Rogers HK, Shah SL. Role of Endoscopic Ultrasound in Pancreatic Cancer Diagnosis and Management. Diagnostics 2024, Vol 14, Page 1156. 2024;14(11):1156. https://doi.org/10.3390/diagnostics14111156

Shin DW, Moon SH, Kim JH. Diagnosis of Cholangiocarcinoma. Diagnostics (Basel). 2023;13(2):233. https://doi.org/10.3390/diagnostics13020233

Van Beers BE. Diagnosis of cholangiocarcinoma. HPB (Oxford). 2008;10(2):87. https://doi.org/10.1080/13651820801992716

Weber A, von Weyhern C, Fend F, Schneider J, Neu B, Meining A, et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World Journal of Gastroenterology: WJG. 2008;14(7):1097. https://doi.org/10.3748/wjg.14.1097

Kurzawinski T, Deery A, Davidson BR. Diagnostic value of cytology for biliary stricture. Br J Surg. 1993;80 (4):414-21. https://doi.org/10.1002/bjs.1800800404

Siu W, Tang RSY. The Role of Cholangioscopy and EUS in the Evaluation of Indeterminate Biliary Strictures. Gastroenterology Insights 2022, Vol 13, Pages 192-205. 2022;13(2):192-205. https://doi.org/10.3390/gastroent13020020

Vasilieva L, Alexopoulou A, Papadhimitriou SI, Romanos A, Xynopoulos D, Dourakis SP. Total bilirubin is a good discriminator between benign and malignant biliary strictures. HPB. 2012;14(1):71. https://doi.org/10.1111/j.1477-2574.2011.00400.x

Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J Gastrointest Oncol. 2012;3(2):105-19. https://doi.org/10.3978/j.issn.2078-6891.2011.021

Naitoh I, Nakazawa T, Kato A, Hayashi K, Miyabe K, Shimizu S, et al. Predictive factors for positive diagnosis of malignant biliary strictures by transpapillary brush cytology and forceps biopsy. J Dig Dis. 2016;17 (1):44-51. https://doi.org/10.1111/1751-2980.12311

Habibzadeh F, Habibzadeh P, Yadollahie M. On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Med (Zagreb). 2016;26 (3):297-307. https://doi.org/10.11613/BM.2016.034

Viesca MFY, Arvanitakis M. Early Diagnosis And Management Of Malignant Distal Biliary Obstruction: A Review On Current Recommendations And Guidelines. Clin Exp Gastroenterol. 2019;12:415. https://doi.org/10.2147/CEG.S195714

Yousaf MN, Chaudhary FS, Ehsan A, Suarez AL, Muniraj T, Jamidar P, Aslanian HR, Farrell JJ. Endoscopic ultrasound (EUS) and the management of pancreatic cancer. BMJ Open Gastroenterol. 2020;7(1):e000408. https://doi.org/10.1136/bmjgast-2020-000408

Njei B, McCarty TR, Varadarajulu S, Navaneethan U. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastrointest Endosc. 2017;85(4):773-781.e10. https://doi.org/10.1016/j.gie.2016.08.020

Kapoor BS, Mauri G, Lorenz JM. Management of Biliary Strictures: State-of-the-Art Review. Radiology. 2018;289(3):590-603. https://doi.org/10.1148/radiol.2018172424

Fujii-Lau LL, Thosani NC, Al-Haddad M, Acoba J, Wray CJ, Zvavanjanja R, et al. American Society for Gastrointestinal Endoscopy guideline on role of endoscopy in the diagnosis of malignancy in biliary strictures of undetermined etiology: methodology and review of evidence. Gastrointest Endosc. 2023;98 (5):694-712.e8. https://doi.org/10.1016/j.gie.2023.06.007

Facciorusso A, Crinò SF, Gkolfakis P, Spadaccini M, Arvanitakis M, Beyna T, et al. Diagnostic work-up of bile duct strictures: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2025;57(2):166-85. https://doi.org/10.1055/a-2481-7048

Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: Findings at MRCP versus ERCP. Radiology. 2004;233(1):234-40. https://doi.org/10.1148/radiol.2331031446

Garcea G, Ngu W, Neal CP, Dennison AR, Berry DP. Bilirubin levels predict malignancy in patients with obstructive jaundice. HPB. 2011;13(6):426-30. https://doi.org/10.1111/j.1477-2574.2011.00312.x

Figura 1. Evaluación de los tiempos y modalidades de diagnóstico según el tipo de neoplasia del tracto biliar. d: días. Imagen propiedad de los autores.

Published

2025-12-23

How to Cite

Zuñiga Cisneros, J., Duarte-Chang, C., McKenzie, A., Quirós, O., & Tuñon, C. (2025). Prospective Analysis of Malignant Biliary Stricture Diagnosis: Experience from a Tertiary-Care Hospital. Revista Colombiana De Gastroenterología, 40(4), 430–440. https://doi.org/10.22516/25007440.1455

Issue

Section

Originals articles

Altmetric

Escanea para compartir
QR Code
Crossref Cited-by logo
Article metrics
Abstract views627
Galley views408
PDF Views319
HTML views0
Other views89

Some similar items: